While there was no significant difference in genomic disruption between NF2-mutant and NF2-wild-type samples, meningiomas with chromosome 22 loss demonstrated increased rates of genomic disruption, even after excluding chromosome 22 (p = 0.05, Fig. 2e). This evidence concerns the gene NF2 and meningioma.